SCHEMBL10073052

SCHEMBL10073052

COc1ccc(C2(CNC(=O)c3ccco3)CCCC2)cc1

nearest known ligand 0.83

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.83
KDM4E B2RXH2 1/20 0.74
LMNA P02545 1/20 0.74
TNKS O95271 2/20 0.67
TNKS2 Q9H2K2 2/20 0.67
PARP1 P09874 1/20 0.67
P2RX7 Q99572 4/20 0.64
POLB P06746 1/20 0.61
SMN1; SMN2 Q16637 1/20 0.56
KMT2A Q03164 3/20 0.55
MEN1 O00255 2/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
RAB9A P51151 1/20 0.53
PKM P14618 1/20 0.53
KCNA3 P22001 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10073049 0.85 ALDH1A1 (0.67) ALDH1A1KDM4ELMNAKMT2AMEN1
SCHEMBL10073031 0.85 LMNA (1.00) ALDH1A1KDM4ELMNAPOLBSMN1; SMN2
SCHEMBL1896657 0.81 TNKS (1.00) ALDH1A1LMNATNKSTNKS2PARP1
SCHEMBL15057522 0.78 TNKS (0.78) ALDH1A1LMNATNKSTNKS2PARP1
SCHEMBL16462872 0.78 P2RX7 (1.00) ALDH1A1LMNAP2RX7POLBKMT2A
SCHEMBL15057674 0.77 TNKS (1.00) ALDH1A1KDM4ELMNATNKSTNKS2
SCHEMBL15057831 0.77 TNKS (0.75) ALDH1A1KDM4ELMNATNKSTNKS2
SCHEMBL15075079 0.77 TNKS (0.73) ALDH1A1LMNATNKSTNKS2PARP1
SCHEMBL27254013 0.77 TNKS (0.85) ALDH1A1LMNATNKSTNKS2PARP1
SCHEMBL16462588 0.76 P2RX7 (1.00) ALDH1A1LMNAP2RX7POLBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130012536-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-01-10 US disclosed
US-20130012536-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-01-10 US disclosed
US-20120035179-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS VERTEX PHARMACEUTICALS INCORPORATED 2012-02-09 US disclosed
US-20100125090-A1 Modulators of ATP-Binding Cassette Transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-05-20 US disclosed
US-20100125090-A1 Modulators of ATP-Binding Cassette Transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-05-20 US disclosed
US-7598412-B2 Modulators of ATP-binding cassette transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2009-10-06 US disclosed
US-7598412-B2 Modulators of ATP-binding cassette transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2009-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130012536-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS ABCB11, ABCB1, ABCC5 ALDH1A1 895/4885KDM4E 4529/4885LMNA 1873/4885
US-20100125090-A1 Modulators of ATP-Binding Cassette Transporters ABCB11, ABCB1, ABCC5 ALDH1A1 895/4885KDM4E 4529/4885LMNA 1873/4885
US-20120035179-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS ABCB11, ABCB1, ABCC5 ALDH1A1 895/4885KDM4E 4529/4885LMNA 1873/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.